P

Pegavision Corp
TWSE:6491

Watchlist Manager
Pegavision Corp
TWSE:6491
Watchlist
Price: 286 TWD -0.52% Market Closed
Market Cap: NT$22.3B

Pegavision Corp
Common Stock

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Pegavision Corp
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
P
Pegavision Corp
TWSE:6491
Common Stock
NT$780m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
N/A
M
Medtecs International Corporation Ltd
SGX:546
Common Stock
$27.5m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Visco Vision Inc
TWSE:6782
Common Stock
NT$630m
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
SciVision Biotech Inc
TWSE:1786
Common Stock
NT$748.3m
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
3%
OK Biotech Co Ltd
TWSE:4155
Common Stock
NT$1.5B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

Pegavision Corp
Glance View

Market Cap
22.3B TWD
Industry
Health Care

Pegavision Corp. focusing on research, development, manufacture and marketing of soft contact lenses and the medical optic devices. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2014-12-30. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
335.13 TWD
Undervaluation 15%
Intrinsic Value
Price NT$286
P

See Also

What is Pegavision Corp's Common Stock?
Common Stock
780m TWD

Based on the financial report for Dec 31, 2025, Pegavision Corp's Common Stock amounts to 780m TWD.

What is Pegavision Corp's Common Stock growth rate?
Common Stock CAGR 5Y
2%

Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for Pegavision Corp have been 4% over the past three years , 2% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett